Vaccinations

World-first UK trial launched for fridge-free vaccine

An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.

The vaccine isn’t a silver bullet for longstanding pressures in elderly care  

Jitesh Patel, Project Director at Kajima Partnerships discusses why the vaccine is not a silver bullet for longstanding pressures in elderly care and how the sector must adapt post-pandemic.

New data shows that Sinovac COVID-19 vaccine is 50.4% effective

The São Paulo Government and Butantan Institute revealed that the Sinovac COVID-19 vaccine is 15.6% less effective than officials previously suggested.

Will COVID-19 vaccination centres be open all night?

Today (13 January) Prime Minister Boris Johnson confirmed that COVID-19 vaccination centres would be running 24/7 "as soon as we can".

Indonesia gives emergency approval to Sinovac COVID-19 vaccine

The country has become the first in the world to approve the Sinovac COVID-19 vaccine, outside of China itself.

EU finalises talks with Valneva to secure a new vaccine

Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.

Over 2.2 million people receive first round of the COVID-19 vaccine

In the UK, over 2.2 million people have received the first round of the COVID-19 vaccine between 8th and 10th December, according to the latest figures.

Community initiative delivers 14,000 COVID-19 tests to Latinx workers

Unidos En Salud organisers have now provided COVID-19 testing to 14,000 people, targeting Latinx workers - one of the most hard-hit communities in San Francisco.

Government plans to vaccinate tens of millions of people by spring

The government has published its UK COVID-19 vaccines delivery plan which aims vaccinate tens of millions of people against COVID-19 by spring.

76% of COVID-19 patients still have one symptom, after six months

While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.

UK approves Moderna COVID vaccine for use

The approval of the Moderna COVID vaccine in the UK comes 2 days after European medical regulators, but not a moment too soon - the death toll continues to climb, standing at 78,508 currently.

Flu vaccine sees highest uptake on record

Over 80% of those aged 65+ in England have received the flu vaccine so far this year – the highest uptake on record.

EU to purchase further 300 million doses of BioNTech-Pfizer vaccine

The European Commission has proposed to purchase an additional 300 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer.

Moderna vaccine approved for use by European Medicines Agency

The EMA joins the US in approving the 94.1% effective Moderna vaccine for use, while the UK still waits on further regulatory discussions.

Some primary schools stay closed due to rising COVID-19 cases

With rising COVID-19 cases, secondary schools will officially remain shut until 18 January - but primary schools across the country have also decided to stay closed.

UK brings in Tier 4 restrictions for South East and London

As of midnight tonight (20 December), London and the South East will enter strict Tier 4 restrictions - which includes no household mixing over Christmas, and no commuting to work.

The rise of real-world data and digital tools: Conducting remote clinical trials in a pandemic

Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders